All News about Bicycle Therapeutics Plc ADR
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/747289/research-scientists-drugs-pharma-biotech.jpg)
![](https://mms.businesswire.com/media/20230911967115/en/1885581/22/BCYC_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Where Bicycle Therapeutics Stands With Analysts
September 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Expert Ratings for Bicycle Therapeutics
August 04, 2023
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230803132124/en/1858257/22/BCYC_logo.jpg)
![](https://mms.businesswire.com/media/20230718530286/en/1842659/22/BCYC_logo.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Bicycle Therapeutics Q1 Earnings
May 04, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/739736/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/13/stratasys_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Bicycle Therapeutics
April 18, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230712446032/en/1840143/22/BCYC_logo.jpg)
![](https://mms.businesswire.com/media/20230622089942/en/1826718/22/BCYC_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230511005119/en/1790156/22/BCYC_logo.jpg)
![](https://mms.businesswire.com/media/20230509006190/en/830197/22/Bayer_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
From Bicycle Therapeutics
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.